{"pub": "yahoo", "url": "https://news.yahoo.com/accelmed-seeks-raise-100-million-082801021.html", "downloaded_at": "2019-10-07 09:12:07.660593+00:00", "title": "Accelmed seeks to raise $100 million for fourth health tech fund", "language": "en", "text": "JERUSALEM (Reuters) - Accelmed, a U.S.-Israel group of funds investing in medical device and digital health companies, said on Monday it was establishing a new fund with the aim of raising and managing $100 million.\n\nThe Accelmed Ventures II fund will invest in Israeli and global pre-revenue health tech startups. Vincent Tchenguiz, a British businessman born in Iran, has committed to invest $15 million in the fund.\n\nThis is the fourth fund established by the Accelmed group, which manages more than $300 million through Accelmed Ventures and private equity fund Accelmed Partners.\n\nAccelmed Ventures I, which was established in 2011, has had a number of exits, including Eximo Medical, purchased by AngioDynamics Inc for $66 million. Portfolio company Endospan signed an option agreement to be acquired by CryoLife Inc for up to $450 million, pursuant to receiving approval by the U.S. Food and Drug Administration.\n\n\n\n\n\n(Reporting by Steven Scheer; Editing by Tova Cohen)", "description": "Accelmed, a U.S.-Israel group of funds investing in medical device and digital health companies, said on Monday it was establishing a new fund with the aim of raising and managing $100 million.  The Accelmed Ventures II fund will invest in Israeli and global pre-revenue health tech startups.  Vincent", "authors": [], "top_image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo.png", "published_at": "2019-10-07"}